Literature DB >> 26707827

Ferlins Show Tissue-Specific Expression and Segregate as Plasma Membrane/Late Endosomal or Trans-Golgi/Recycling Ferlins.

Gregory M I Redpath1,2, Reece A Sophocleous1, Lynne Turnbull3, Cynthia B Whitchurch3, Sandra T Cooper1,2.   

Abstract

Ferlins are a family of transmembrane-anchored vesicle fusion proteins uniquely characterized by 5-7 tandem cytoplasmic C2 domains, Ca(2+)-regulated phospholipid-binding domains that regulate vesicle fusion in the synaptotagmin family. In humans, dysferlin mutations cause limb-girdle muscular dystrophy type 2B (LGMD2B) due to defective Ca(2+)-dependent, vesicle-mediated membrane repair and otoferlin mutations cause non-syndromic deafness due to defective Ca(2+)-triggered auditory neurotransmission. In this study, we describe the tissue-specific expression, subcellular localization and endocytic trafficking of the ferlin family. Studies of endosomal transit together with 3D-structured illumination microscopy reveals dysferlin and myoferlin are abundantly expressed at the PM and cycle to Rab7-positive late endosomes, supporting potential roles in the late-endosomal pathway. In contrast, Fer1L6 shows concentrated localization to a specific compartment of the trans-Golgi/recycling endosome, cycling rapidly between this compartment and the PM via Rab11 recycling endosomes. Otoferlin also shows trans-Golgi to PM cycling, with very low levels of PM otoferlin suggesting either brief PM residence, or rare incorporation of otoferlin molecules into the PM. Thus, type-I and type-II ferlins segregate as PM/late-endosomal or trans-Golgi/recycling ferlins, consistent with different ferlins mediating vesicle fusion events in specific subcellular locations.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Fer1L4; Fer1L5; Fer1L6; Rab7; dysferlin; late endosome; myoferlin; otoferlin; recycling endosome; trans-Golgi

Mesh:

Substances:

Year:  2016        PMID: 26707827     DOI: 10.1111/tra.12370

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  19 in total

1.  Variants in the Oxidoreductase PYROXD1 Cause Early-Onset Myopathy with Internalized Nuclei and Myofibrillar Disorganization.

Authors:  Gina L O'Grady; Heather A Best; Tamar E Sztal; Vanessa Schartner; Myriam Sanjuan-Vazquez; Sandra Donkervoort; Osorio Abath Neto; Roger Bryan Sutton; Biljana Ilkovski; Norma Beatriz Romero; Tanya Stojkovic; Jahannaz Dastgir; Leigh B Waddell; Anne Boland; Ying Hu; Caitlin Williams; Avnika A Ruparelia; Thierry Maisonobe; Anthony J Peduto; Stephen W Reddel; Monkol Lek; Taru Tukiainen; Beryl B Cummings; Himanshu Joshi; Juliette Nectoux; Susan Brammah; Jean-François Deleuze; Viola Oorschot Ing; Georg Ramm; Didem Ardicli; Kristen J Nowak; Beril Talim; Haluk Topaloglu; Nigel G Laing; Kathryn N North; Daniel G MacArthur; Sylvie Friant; Nigel F Clarke; Robert J Bryson-Richardson; Carsten G Bönnemann; Jocelyn Laporte; Sandra T Cooper
Journal:  Am J Hum Genet       Date:  2016-10-13       Impact factor: 11.025

Review 2.  Molecular Therapies for Muscular Dystrophies.

Authors:  Ava Y Lin; Leo H Wang
Journal:  Curr Treat Options Neurol       Date:  2018-06-21       Impact factor: 3.598

Review 3.  Muscle cell communication in development and repair.

Authors:  Alexis R Demonbreun; Elizabeth M McNally
Journal:  Curr Opin Pharmacol       Date:  2017-04-15       Impact factor: 5.547

4.  Limited proteolysis as a tool to probe the tertiary conformation of dysferlin and structural consequences of patient missense variant L344P.

Authors:  Natalie Woolger; Adam Bournazos; Reece A Sophocleous; Frances J Evesson; Angela Lek; Birgit Driemer; R Bryan Sutton; Sandra T Cooper
Journal:  J Biol Chem       Date:  2017-09-13       Impact factor: 5.157

5.  RIPK3 modulates growth factor receptor expression in endothelial cells to support angiogenesis.

Authors:  Siqi Gao; Courtney T Griffin
Journal:  Angiogenesis       Date:  2021-01-15       Impact factor: 10.658

6.  BAIAP3, a C2 domain-containing Munc13 protein, controls the fate of dense-core vesicles in neuroendocrine cells.

Authors:  Xingmin Zhang; Shan Jiang; Kelly A Mitok; Lingjun Li; Alan D Attie; Thomas F J Martin
Journal:  J Cell Biol       Date:  2017-06-16       Impact factor: 10.539

7.  Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes.

Authors:  Arnaud Blomme; Karim Fahmy; Olivier Peulen; Brunella Costanza; Marie Fontaine; Ingrid Struman; Dominique Baiwir; Edwin de Pauw; Marc Thiry; Akeila Bellahcène; Vincent Castronovo; Andrei Turtoi
Journal:  Oncotarget       Date:  2016-12-13

8.  A small molecule targeting myoferlin exerts promising anti-tumor effects on breast cancer.

Authors:  Tao Zhang; Jingjie Li; Yuan He; Feifei Yang; Yun Hao; Wangrui Jin; Jing Wu; Zhenliang Sun; Yunqi Li; Yihua Chen; Zhengfang Yi; Mingyao Liu
Journal:  Nat Commun       Date:  2018-09-13       Impact factor: 14.919

9.  Fer1l6 is essential for the development of vertebrate muscle tissue in zebrafish.

Authors:  Josephine A Bonventre; Chelsea Holman; Aayushi Manchanda; Sara J Codding; Trisha Chau; Jacob Huegel; Carrie Barton; Robert Tanguay; Colin P Johnson
Journal:  Mol Biol Cell       Date:  2018-12-05       Impact factor: 4.138

10.  In vitro gentamicin exposure alters caveolae protein profile in cochlear spiral ligament pericytes.

Authors:  Elisa Ghelfi; Yohann Grondin; Emil J Millet; Adam Bartos; Magda Bortoni; Clara Oliveira Gomes Dos Santos; Humberto J Trevino-Villarreal; Rosalinda Sepulveda; Rick Rogers
Journal:  Proteome Sci       Date:  2018-03-16       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.